Latest filing published 20 Aug 2026 for Adaptive Biotechnologies Corporation, €8.8M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Harlan Robins: trading record in brief
Harlan Robins is a declared insider of Adaptive Biotechnologies Corp, with filings sourced from SEC (Form 4). In total, 8 filings cover trades dated from 15 June 2026 to 20 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 20 August 2026 with a transaction (€8.8M) in Adaptive Biotechnologies Corp. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harlan Robins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 402,160 shares@ US$25.44Common StockSEC144:0001958244-26-000543
- 215,632 shares@ US$25.490.14% mcap13.5% of flowCommon StockSEC144:0001958244-26-000536
- 261,044 shares@ US$24.560.16% mcap18.2% of flowCommon StockSEC144:0001958244-26-000526
- 300,992 shares@ US$24.770.19% mcap25.8% of flowCommon StockSEC144:0001958244-26-000523
- 492,400 shares@ US$22.5852.6% of flowCommon StockSEC144:0001958244-26-000463
- 386,240 shares@ US$21.19100.0% of flowCommon StockSEC144:0001958244-26-000428
- 6,160 shares@ US$17.221.0% of flowCommon StockSEC144:0001958244-26-000386
- 100,000 shares@ US$17.4617.2% of flowCommon StockSEC144:0001958244-26-000379
8 of 8 declarations
